Department of Urology, University of California San Francisco, San Francisco, California.
Spokane Urology, Spokane, Washington.
J Urol. 2022 Apr;207(4):857-865. doi: 10.1097/JU.0000000000002353. Epub 2021 Dec 2.
Postoperative surveillance urethroscopy has been shown to be an effective tool to predict reoperation within 1 year after urethroplasty. We aimed to evaluate early surveillance urethroscopy findings and long-term outcomes among urethroplasty patients in order to define the value of surveillance urethroscopy to predict failure.
We evaluated 304 patients with at least 4 years of followup after urethroplasty performed at 10 institutions across the United States and Canada. All patients were surveilled using a flexible 17Fr cystoscope and were categorized into 3 groups: 1) normal lumen, 2) large-caliber stricture (≥17Fr) defined as the ability of the cystoscope to easily pass the narrowing and 3) small-caliber stricture (<17Fr) that the cystoscope could not be passed. Failure was stricture recurrence requiring a secondary intervention.
The median followup time was 64.4 months (range 55.3-80.6) and the time to initial surveillance urethroscopy was 3.7 months (range 3.1-4.8) following urethroplasty. Secondary interventions were performed in 29 of 194 (15%) with normal lumens, 11 of 60 (18.3%) with ≥17Fr strictures and 32 of 50 (64%) with <17Fr strictures (p <0.001). The 1-, 3- and 9-year cumulative probability of intervention was 0.01, 0.06 and 0.23 for normal, 0.05, 0.17 and 0.18 for ≥17Fr, and 0.32, 0.50 and 0.73 for <17Fr lumen groups, respectively. Patient-reported outcome measures performed poorly to differentiate the 3 groups.
Early cystoscopic visualization of scar recurrence that narrows the lumen to <17Fr following urethroplasty is a significant long-term predictor for patients who will eventually undergo a secondary intervention.
术后尿道镜检查已被证明是一种有效的工具,可以预测尿道成形术后 1 年内的再次手术。我们旨在评估尿道成形术后患者的早期尿道镜检查结果和长期结局,以确定尿道镜检查对预测失败的价值。
我们评估了在美国和加拿大 10 个机构进行尿道成形术的 304 例至少随访 4 年的患者。所有患者均采用柔性 17Fr 膀胱镜进行监测,并分为 3 组:1)正常管腔,2)大口径狭窄(≥17Fr)定义为膀胱镜能够轻松通过狭窄部位,3)小口径狭窄(<17Fr),即膀胱镜无法通过。失败定义为需要二次干预的狭窄复发。
中位随访时间为 64.4 个月(范围 55.3-80.6),尿道成形术后首次尿道镜检查时间为 3.7 个月(范围 3.1-4.8)。在正常管腔的 194 例中有 29 例(15%)需要二次干预,在≥17Fr 狭窄的 60 例中有 11 例(18.3%)需要二次干预,在<17Fr 狭窄的 50 例中有 32 例(64%)需要二次干预(p<0.001)。正常、≥17Fr 和<17Fr 管腔组的 1、3 和 9 年累积干预概率分别为 0.01、0.06 和 0.23、0.05、0.17 和 0.18、0.32、0.50 和 0.73。患者报告的结局测量结果在区分这 3 组方面表现不佳。
尿道成形术后早期膀胱镜检查发现瘢痕复发导致管腔狭窄至<17Fr 是预测患者最终需要二次干预的重要长期指标。